News Category:

Company News

PROMISING RESEARCH COULD LEAD TO NEW TREATMENT FOR DEADLY BRAIN CANCER

Dr. Bo Xu, left, chair of Southern Research’s oncology department, works with Josh Fried, a researcher in his lab.

Southern Research oncology researcher Dr. Bo Xu, M.D., Ph.D., says new research suggests combining an experimental enzyme blocker and a standard chemotherapy drug could improve treatments ...
news categories: ,

USA Researchers Aid in Fight Against Superbug

USA researchers Dr. Jonathon Audia, right, and Dr. Diego Alvarez recently developed a model of bacterial sepsis and pneumonia that can aid in the fight against antibiotic-resistant bacteria.

Researchers at the University of South Alabama College of Medicine are aiding in the fight ...

EVONIK MARKS 40 YEARS OF PRODUCTION AT ITS MOBILE, ALABAMA SITE

Evonik Corporation celebrated 40 years of production at its Mobile, Alabama, site with four $10,000 donations to local organizations focused on science, education, workforce training and healthcare. The Mobile specialty chemical manufacturing site is Evonik’s largest in North America with more than 800 employees and an additional ...
news categories:

UAB awarded $250,000 grant to uncover root causes of lupus

The Lupus Research Alliance recently awarded the University of Alabama at Birmingham a one-year grant of $250,000 to investigate a new explanation for how lupus develops and the reason some people, particularly blacks, are at greater risk for flare-ups and kidney disease. The work will be reviewed for ...

RESEARCHER DEVELOPING NEW TOXICOLOGY TEST TO PROTECT UNBORN CHILDREN

Southern Research reproductive toxicology scientist Paul Bushdid, Ph.D., is working to develop a new, cost-efficient laboratory test to evaluate hazards to unborn children posed by potential medicines, chemicals and other agents. Bushdid’s in vitro toxicology model, based on a chicken embryo, promises to deliver significant benefits. For one thing, the model should produce more rapid hazard assessments of ...
news categories: ,

iCubate® to present FDA cleared pathogenic bacteria detection system at AMP Meeting

Huntsville, Ala. November 13, 2017 – iCubate®, Inc., an innovative molecular diagnostic device company, announced today that it will host a workshop presentation at the Association of Molecular Pathology (AMP) meeting in Salt Lake City, Utah. The presentation will be on Wednesday, November 15 at 4 pm at the Calvin ...

New NIH-funded studies will examine risk factors for age-related diseases

Liou Sun, Ph.D.

biology lab at the University of Alabama at Birmingham gains increased funding with the addition of two grants from the National Institutes of Health. The research team will use the funding to better understand the correlation between the biology of aging and neurodegenerative ...

Care could improve for dialysis patients with development of bionanomatrix gel with $2 million grant

End stage kidney disease affects more than 600,000 people in the United States. A team of physicians and researchers from the University of Alabama at Birmingham and spinoff startup company Endomimetics is looking to improve the care for these patients with a grant from the National Institutes of Health. More ...

NSF grant funds UAH optics major’s research on ultrafast nanophotonics

Thanks to a supplemental grant from the NSF, UAH senior optical engineering major Dane Rich was able to spend the summer conducting research on ultrafast nanophotonics under the supervision of Dr. Lingze Duan.

When Dr. Lingze Duan, associate professor in the Department of ...

Southern Research & Bionetix collaboration seeks novel cancer drug that targets a genetic switch

Southern Research and Bionetix Inc., a South Korea-based biotech firm, have signed a research and license agreement to develop a new anti-cancer drug that affects a key genetic switch associated with suppression and regulation of the growth of certain types of cancer. The goal of the research is to develop a novel drug that would block, ...